Digital Health Technology and Reciprocal Innovation to Improve Clinical and Public Health Outcomes

The Digital Health Technology and Reciprocal Innovation to Improve Clinical and Public Health Outcomes opportunity is a federal research initiative issued by the National Institutes of Health within the U.S. Department of Health and Human Services. This program is aligned with the agency’s broader mission to advance biomedical and public health research that improves health outcomes both domestically and globally. Specifically, this initiative is connected to international research and training priorities and is designed to strengthen collaboration between U.S. institutions and partners in low- and middle-income countries. The program emphasizes innovation in digital health technologies and seeks to expand the evidence base for their application in addressing high-priority health challenges. The primary purpose of this funding opportunity is to support the development, validation, feasibility testing, and effectiveness evaluation of digital health tools and interventions. These tools may include mobile health applications, data analytics systems, digital platforms, and emerging technologies designed to improve clinical care delivery and public health outcomes. The initiative prioritizes solutions that are adaptable to underserved environments, both within the United States and internationally, particularly in resource-constrained settings. Projects are expected to address significant health challenges and demonstrate potential for scalability and broad impact. A defining feature of this program is its requirement for reciprocal innovation. Applicants must incorporate bidirectional collaboration between U.S. researchers and those in low- and middle-income countries. This approach requires the exchange of ideas, data, methodologies, and innovations in a way that benefits all participating regions. By leveraging diverse populations, environments, and health systems, the program aims to generate knowledge that is generalizable and applicable across multiple contexts. This emphasis on collaboration ensures that funded projects not only address local needs but also contribute to global health advancements. Funding is provided through a grant mechanism, although specific award amounts, ceilings, and total program funding levels are not disclosed in the forecasted announcement. There is no cost sharing or matching requirement associated with this opportunity, which lowers the financial barrier for applicants. While detailed allowable and unallowable cost categories are not specified in the forecast, typical NIH grants support personnel, research activities, data collection, technology development, and collaboration-related expenses consistent with federal grant guidelines. Eligibility for this opportunity is broad and inclusive, encompassing a wide range of domestic and international entities. Eligible applicants include state and local governments, tribal governments and organizations, public and private institutions of higher education, nonprofit organizations with or without federal tax-exempt status, small businesses, and for-profit entities. Additionally, foreign institutions and organizations based in U.S. territories or possessions are eligible to apply. This expansive eligibility framework reflects the program’s global scope and its intent to foster diverse partnerships across sectors and regions. The application process is expected to follow standard NIH submission procedures, although specific submission components are not detailed in the forecast. Applicants will likely be required to submit a full research proposal outlining project objectives, methodology, collaboration structure, and expected outcomes. Applications will be evaluated based on their scientific merit, innovation, feasibility, and potential impact on clinical and public health outcomes. Collaboration strength and the integration of reciprocal innovation principles are also expected to be key evaluation criteria. The timeline indicates that the opportunity is currently in a forecast stage, with an estimated posting date of December 1, 2026, and an application due date of February 11, 2027. Awards are anticipated to be made by December 1, 2027, with project activities beginning shortly thereafter. As a forecasted opportunity, this program provides early visibility for prospective applicants to begin planning partnerships and research concepts. No recurrence pattern is explicitly stated, though similar NIH programs are often released periodically. Applicants are encouraged to monitor updates and prepare in advance for submission once the full notice is released.